LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT
Global Journal of Medical and Pharmaceutical Sciences · 2023
DOI: 10.55640/gjmps-abcd05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Medical and Pharmaceutical Sciences, 2023. Verfasst von Abdullahi Ebenezer und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Lassa fever, caused by the Lassa virus, is a severe viral hemorrhagic fever with significant public health implications in West Africa. The disease poses a substantial burden on affected communities, leading to high morbidity and mortality rates. As an emerging infectious disease threat, Lassa fever presents challenges in terms of prevention, diagnosis, and control. This paper explores strategies for mitigating the risk of Lassa fever transmission and outbreak escalation. Key components of Lassa fever mitigation efforts include public health education, community engagement, surveillance and early detection, vector control measures, healthcare worker protection, and vaccine development. By implementing multidimensional approaches that address both environmental and behavioral factors, stakeholders can enhance preparedness and response capabilities to combat the spread of Lassa fever and minimize its impact on public health.
Zitieren
APA
Ebenezer, A., & Adesewa, S. (2023). LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT. Global Journal of Medical and Pharmaceutical Sciences. https://doi.org/10.55640/gjmps-abcd05
Vancouver
Ebenezer A, Adesewa S. LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT. Global Journal of Medical and Pharmaceutical Sciences. 2023. doi:10.55640/gjmps-abcd05
BibTeX
@article{Ebenezer2023,
author = {Ebenezer, Abdullahi and Adesewa, Samuel},
title = {LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT},
journal = {Global Journal of Medical and Pharmaceutical Sciences},
year = {2023},
doi = {10.55640/gjmps-abcd05}
}
EUVIMED